Literature DB >> 32621996

HCQ induced QT prolongation- Primum non nocere.

A J Mahendran1, Nitesh Gupta2, Pranav Ish3.   

Abstract

Entities:  

Keywords:  Coronavirus; Guidelines; Hydroxychloroquine; QT prolongation

Year:  2020        PMID: 32621996      PMCID: PMC7327444          DOI: 10.1016/j.ipej.2020.06.009

Source DB:  PubMed          Journal:  Indian Pacing Electrophysiol J        ISSN: 0972-6292


× No keyword cloud information.
To the Editor, The article ‘Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society’ by Kapoor et al. [1] is a much-needed guideline for use of hydroxychloroquine (HCQ) in the current COVID-19 pandemic. It recommends performing a baseline electrocardiograph (ECG) and calculation QTc prior to starting HCQ. Based on the existing evidences, though not conclusive, HCQ has been recommended for use as prophylaxis and treatment of COVID-19 in many guidelines. Although it is a safe drug, a serious adverse effect is QT prolongation, culminating in Torsades des Pointes or polymorphic ventricular tachycardia, leading to sudden cardiac death. Unfortunately, only few published literatures speak about the adverse reaction and precautions to be taken before using the drug (Table 1).
Table 1

The available literature on hydroxychloroquine induced electrocardiographic changes and current recommendations.

No.Study/Recommendation/GuidelineUpdated/PublishedRecommendation
1Indian pacing and electrophysiology journal [1]April, 2020Recommends baseline ECG in all and Bazett formula
2CDC [3]April 7, 2020Follow FDA approval recommendation
3FDA [4]March 28, 2020No recommendation
4European medicine agenciesApril 7, 2020No recommendation (against use)
5The centre for evidence-based medicineMarch 25, 2020No recommendation
6American College of Cardiology [5]March 29, 2020Fridericia/Framingham formula for QTc
7ICMRMarch 21, 2020No recommendation
8BMJ- best practise [3]April 7, 2020No recommendation
9WHO- Landscape analysis of therapeutics [3]March 21, 2020No recommendation

CDC- Centre for disease control, FDA- Food and Drug Administration, ICMR- Indian council of medical research, BMJ- British medical journal, WHO- World health organisation.

The available literature on hydroxychloroquine induced electrocardiographic changes and current recommendations. CDC- Centre for disease control, FDA- Food and Drug Administration, ICMR- Indian council of medical research, BMJ- British medical journal, WHO- World health organisation. It is well known fact that QTc is calculated using various formulae viz., Bazett, Fridericia, Framingham, Hodges and Rautaharju. For drug induced QTc prolongation, the study by Vanderberk et al. advocated to use Fridericia or Framingham formula instead of Bazett formula, which may under correct QTc prolongation at low heart rate and overcorrect at high heart rate [2]. However, the Indian heart rhythm society [1] has recommended use of Bazett formula. In view of lack of studies comparing various formulae on a head-to-head basis and ease of using online calculators, the reason for choosing the particular formula is unclear. There is an urgent need to carry out further studies to look into the occurrence of Torsades de pointes and QTc prolongation with HCQ using various formulae and develop international guidelines for the same.

Funding

Financial support and sponsorship- Nil.

Contributions

All the 3 authors contributed to –Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; & Drafting the work or revising it critically for important intellectual content; & Final approval of the version to be published; & Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  2 in total

1.  Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.

Authors:  Aditya Kapoor; Ulhas Pandurangi; Vanita Arora; Anoop Gupta; Aparna Jaswal; Ashish Nabar; Ajay Naik; Nitish Naik; Narayanan Namboodiri; Amit Vora; Rakesh Yadav; Anil Saxena
Journal:  Indian Pacing Electrophysiol J       Date:  2020-04-08

2.  Which QT Correction Formulae to Use for QT Monitoring?

Authors:  Bert Vandenberk; Eline Vandael; Tomas Robyns; Joris Vandenberghe; Christophe Garweg; Veerle Foulon; Joris Ector; Rik Willems
Journal:  J Am Heart Assoc       Date:  2016-06-17       Impact factor: 5.501

  2 in total
  1 in total

1.  Reply to letters regarding our paper "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Societyˮ.

Authors:  Aditya Kapoor; Ulhas Pandurangi; Vanita Arora; Anoop Gupta; Aparna Jaswal; Ashish Nabar; Ajay Naik; Nitish Naik; Narayanan Namboodiri Kk; Amit Vora; Rakesh Yadav; Anil Saxena
Journal:  Indian Pacing Electrophysiol J       Date:  2020-07-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.